Identification of non–severe combined immune deficiency T-cell lymphopenia at newborn screening for severe combined immune deficiency

Kwan, 2014, Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States, JAMA, 312, 729, 10.1001/jama.2014.9132

Shearer, 2014, Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience, J Allergy Clin Immunol, 133, 1092, 10.1016/j.jaci.2013.09.044

Dorsey, 2017, Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening, J Allergy Clin Immunol, 139, 733, 10.1016/j.jaci.2017.01.005

Blom, 2017, An evaluation of the TREC assay with regard to the intergration of SCID screening into the Dutch newborn screening program, Clin Immunol, 180, 106, 10.1016/j.clim.2017.05.007

Albin-Leeds, 2017, Idiopathic T cell lymphopenia identified in New York State Newborn Screening, Clin Immunol, 183, 36, 10.1016/j.clim.2017.07.002

Ding, 2016, Cost effective/cost-benefit analysis of newborn screening for severe combined immune deficiency in Washington State, J Pediatr, 172, 127, 10.1016/j.jpeds.2016.01.029